Liposomes Modified with Cyclic RGD Peptide for Tumor Targeting
暂无分享,去创建一个
Sanyog Jain | S. Mahor | S. Vyas | V. Mishra | S. P. Vyas | P. Dubey | S. P. Vyas
[1] T. Okano,et al. PhenotypeCells Possessing the Side Population Properties of Quiescent Hemopoietic Stem Is Correlated to the 3 b Expression of Integrin , 2006 .
[2] R. Schiffelers,et al. Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[3] R. Hynes. A reevaluation of integrins as regulators of angiogenesis , 2002, Nature Medicine.
[4] A. Schätzlein,et al. Solid-phase synthesis of c(RGDfK) derivatives: on-resin cyclisation and lysine functionalisation. , 2002, Bioorganic & medicinal chemistry letters.
[5] Grietje Molema,et al. Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeutics. , 2002, Bioconjugate chemistry.
[6] B. Singh,et al. Expression of integrin alphavbeta3 in pig, dog and cattle. , 2001, Histology and histopathology.
[7] B. Neustadt,et al. Targeting Integrins αvβ3 and αvβ5 for Bloking Tumor-Induced Angiogenesis , 2000 .
[8] B. Neustadt,et al. Targeting integrins alpha v beta 3 and alpha v beta 5 for blocking tumor-induced angiogenesis. , 2000, Advances in experimental medicine and biology.
[9] M. Detmar,et al. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[10] Erkki Ruoslahti,et al. Anti-cancer activity of targeted pro-apoptotic peptides , 1999, Nature Medicine.
[11] Willis,et al. Ligand-targeted liposomes. , 1998, Advanced drug delivery reviews.
[12] E. Ruoslahti,et al. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.
[13] F. Martin. CHAPTER 8.2 – Clinical pharmacology and antitumor efficacy of DOXIL (pegylated liposomal doxorubicin) , 1998 .
[14] Thomas Boehm,et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.
[15] L. Thiberville,et al. Simple high-performance liquid chromatographic method for the quantitation of 5-fluorouracil in human plasma. , 1996, Journal of chromatography. B, Biomedical applications.
[16] David A. Cheresh,et al. Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.
[17] Erkki Ruoslahti,et al. Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins , 1995, Bio/Technology.
[18] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[19] D. Cheresh,et al. Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. , 1991, The Journal of clinical investigation.
[20] G. Fields,et al. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.
[21] D. Marsh. CRC handbook of lipid bilayers , 1990 .
[22] W. Ershler,et al. Investigation of tumor angiogenesis in an id mouse model: role of host-tumor interactions. , 1988, Journal of the National Cancer Institute.
[23] I. Fidler. The Ernst W. Bertner Memorial Award lecture: the evolution of biological heterogeneity in metastatic neoplasms. , 1983, Symposium on Fundamental Cancer Research.
[24] F. Szoka,et al. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[25] E. Jaffe,et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.
[26] I. Fidler,et al. Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.
[27] G. R. Bartlett. Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.
[28] G. Molema,et al. Preparation and Functional Evaluation of RGD-Modified Proteins as r v â 3 Integrin Directed Therapeutics , 2022 .